Cancer cell metabolism as new targets for novel designed therapies. (October 2014)

• Record Type: Journal Article
• Authors: de Mas, Igor Marín; Aguilar, Esther; Jayaraman, Anusha; Polat, Ibrahim H; Martín-Bernabé, Alfonso; Bharat, Rohit; Foguet, Carles; Milà, Enric; Papp, Balázs; Centelles, Josep J; Cascante, Marta
• Is Part Of: Future medicinal chemistry. Volume 6:Number 16(2014)
• Page Start: 1791
• Page End: 1810
• Publication Date: 2014-10
• Subjects: Pharmaceutical chemistry -- Periodicals; 615.19005
• DOI: 10.4155/fmc.14.119
• Languages: English
• ISSNs: 1756-8919

Abstract

Metabolic processes are altered in cancer cells, which obtain advantages from this metabolic reprogramming in terms of energy production and synthesis of biomolecules that sustain their uncontrolled proliferation. Due to the conceptual progresses in the last decade, metabolic reprogramming was recently included as one of the new hallmarks of cancer. The advent of high-throughput technologies to amass an abundance of omic data, together with the development of new computational methods that allow the integration and analysis of omic data by using genome-scale reconstructions of human metabolism, have increased and accelerated the discovery and development of anticancer drugs and tumor-specific metabolic biomarkers. Here we review and discuss the latest advances in the context of metabolic reprogramming and the future in cancer research.